BURKITT LYMPHOMA
Clinical trials for BURKITT LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new BURKITT LYMPHOMA trials appear
Sign up with your email to follow new studies for BURKITT LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets Hard-to-Treat blood cancers
Disease control Not yet recruitingThis early-stage study tests a new drug called LY4152199 in people with B-cell cancers like lymphoma that have not responded to prior treatments. The main goals are to find the safest dose and see if the drug can shrink tumors. About 215 adults will take part, and those who benef…
Matched conditions: BURKITT LYMPHOMA
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
Experimental Dual-Targeting cell therapy takes on tough lymphomas
Disease control Not yet recruitingThis early-phase study tests a new type of immune cell therapy (bispecific AbTCR-T cells) in 3 adults with relapsed or refractory B-cell lymphoma. The cells are designed to recognize two targets (CD19 and CD22) on cancer cells. The main goal is to check safety and side effects, w…
Matched conditions: BURKITT LYMPHOMA
Phase: EARLY_PHASE1 • Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Disease control
Last updated May 26, 2026 08:32 UTC